药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Pirbuterol
Oxitropium
The risk or severity of urinary retention can be increased when Oxitropium is combined with Mirabegron.
Pirbuterol
Revefenacin
The risk or severity of urinary retention can be increased when Revefenacin is combined with Mirabegron.
Pirbuterol
Methscopolamine
The risk or severity of urinary retention can be increased when Methscopolamine is combined with Mirabegron.
Pirbuterol
Thonzylamine
The risk or severity of urinary retention can be increased when Thonzylamine is combined with Mirabegron.
Pirbuterol
Butylscopolamine
The risk or severity of urinary retention can be increased when Butylscopolamine is combined with Mirabegron.
Pirbuterol
Imidafenacin
The risk or severity of urinary retention can be increased when Imidafenacin is combined with Mirabegron.
Pirbuterol
Dosulepin
The risk or severity of urinary retention can be increased when Dosulepin is combined with Mirabegron.
Pirbuterol
Trimebutine
The risk or severity of urinary retention can be increased when Trimebutine is combined with Mirabegron.
Pirbuterol
Umeclidinium
The risk or severity of urinary retention can be increased when Umeclidinium is combined with Mirabegron.
Pirbuterol
Benactyzine
The risk or severity of urinary retention can be increased when Benactyzine is combined with Mirabegron.
Pirbuterol
Dexetimide
The risk or severity of urinary retention can be increased when Dexetimide is combined with Mirabegron.
Pirbuterol
Aclidinium
The risk or severity of urinary retention can be increased when Aclidinium is combined with Mirabegron.
Pirbuterol
Dimetindene
The risk or severity of urinary retention can be increased when Dimetindene is combined with Mirabegron.
Pirbuterol
Hexocyclium
The risk or severity of urinary retention can be increased when Hexocyclium is combined with Mirabegron.
Pirbuterol
Pizotifen
The risk or severity of urinary retention can be increased when Pizotifen is combined with Mirabegron.
Pirbuterol
Mepenzolate
The risk or severity of urinary retention can be increased when Mepenzolate is combined with Mirabegron.
Pirbuterol
Rapacuronium
The risk or severity of urinary retention can be increased when Rapacuronium is combined with Mirabegron.
Pirbuterol
Isopropamide
The risk or severity of urinary retention can be increased when Isopropamide is combined with Mirabegron.
Pirbuterol
Methotrimeprazine
The risk or severity of urinary retention can be increased when Methotrimeprazine is combined with Mirabegron.
Pirbuterol
Pipecuronium
The risk or severity of urinary retention can be increased when Pipecuronium is combined with Mirabegron.